Stonepine Capital Management, LLC 13D and 13G filings for aTyr Pharma, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2024-02-13 4:30 pm Sale | 2023-12-31 | 13G | aTyr Pharma, Inc. ATYR | Stonepine Capital Management, LLC | 482,258 0.800% | -4,087,175 (-89.45%) | Filing |
| 2023-04-28 6:31 pm Purchase | 2023-04-19 | 13G | aTyr Pharma, Inc. ATYR | Stonepine Capital Management, LLC | 4,743,162 4.400% | 4,743,162 (New Position) | Filing |
| 2023-02-17 5:04 pm Purchase | 2023-02-09 | 13G | aTyr Pharma, Inc. ATYR | Stonepine Capital Management, LLC | 4,569,433 8.900% | 4,569,433 (New Position) | Filing |